PITTSBURGH, Dec. 14 /PRNewswire-FirstCall/ -- Mylan Inc. today announced that the company will be added to the NASDAQ-100 Index Dec. 21. Mylan’s common shares will also be included in NASDAQ’s PowerShares QQQ.
The NASDAQ-100 Index consists of 100 of the largest, most innovative domestic and international non-financial securities listed on The NASDAQ Stock Market based on market capitalization. The Index reflects companies across major industry groups, including computer hardware and software, telecommunications, retail and wholesale trade, and biotechnology.
Mylan Inc. ranks among the leading generic and specialty pharmaceutical companies in the world and provides products to customers in more than 140 countries and territories. The company maintains one of the industry’s broadest and highest quality product portfolios supported by a robust product pipeline; operates one of the world’s largest active pharmaceutical ingredient manufacturers; and runs a specialty business focused on respiratory, allergy and psychiatric therapies. For more information, please visit www.mylan.com.
CONTACT: Michael Laffin (Media), +1-724-514-1968, or Dan Crookshank,
(Investors), +1-724-514-1813, both of Mylan Inc.
Web site: http://www.mylan.com/
